4D Molecular Therapeutics, Inc. financial data

Symbol
FDMT on Nasdaq
Location
5858 Horton Street #455, Emeryville, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.32K % -44%
Debt-to-equity 10.2 % +49.5%
Return On Equity -40.2 % -66.8%
Return On Assets -36.4 % -61.7%
Operating Margin -508K % -93113%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +49.8%
Common Stock, Shares, Outstanding 46.7M shares -10%
Entity Public Float 1.04B USD +65.7%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 55.9M shares +1.17%
Weighted Average Number of Shares Outstanding, Diluted 55.9M shares +1.17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 37K USD -99.8%
Revenue from Contract with Customer, Excluding Assessed Tax 33K USD -99.8%
General and Administrative Expense 50.1M USD +23.5%
Operating Income (Loss) -220M USD -67.9%
Nonoperating Income (Expense) 24.2M USD +13.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -196M USD -78.5%
Earnings Per Share, Basic -3 USD/shares -59%
Earnings Per Share, Diluted -3 USD/shares -59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 77.2M USD -59.2%
Marketable Securities, Current 216M USD -38.8%
Assets, Current 303M USD -45.1%
Property, Plant and Equipment, Net 17.5M USD -6.7%
Operating Lease, Right-of-Use Asset 19.6M USD +83.8%
Other Assets, Noncurrent 9.39M USD +305%
Assets 474M USD -23.6%
Accounts Payable, Current 8.7M USD +154%
Employee-related Liabilities, Current 6.86M USD +24.9%
Accrued Liabilities, Current 19.2M USD +50.2%
Contract with Customer, Liability, Current 1.07M USD
Liabilities, Current 34.7M USD +78.7%
Contract with Customer, Liability, Noncurrent 219K USD -83.4%
Operating Lease, Liability, Noncurrent 17.4M USD +65.9%
Other Liabilities, Noncurrent 161K USD -24.8%
Liabilities 52.7M USD +66%
Accumulated Other Comprehensive Income (Loss), Net of Tax 337K USD
Retained Earnings (Accumulated Deficit) -679M USD -40.6%
Stockholders' Equity Attributable to Parent 421M USD -28.5%
Liabilities and Equity 474M USD -23.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.8M USD -64.2%
Net Cash Provided by (Used in) Financing Activities 319M USD +2800%
Net Cash Provided by (Used in) Investing Activities 31.9M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 46.7M shares -10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.8M USD -160%
Deferred Tax Assets, Valuation Allowance 128M USD +8.98%
Deferred Tax Assets, Gross 134M USD +9.08%
Operating Lease, Liability 23.1M USD +69%
Depreciation 5M USD +6.38%
Payments to Acquire Property, Plant, and Equipment 631K USD -11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -196M USD -76.9%
Lessee, Operating Lease, Liability, to be Paid 30.4M USD +82.8%
Property, Plant and Equipment, Gross 36.3M USD +9.82%
Operating Lease, Liability, Current 5.72M USD +79%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.35M USD +70.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.6M USD +72.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +38.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.36M USD +146%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.51M USD +96.1%
Deferred Tax Assets, Operating Loss Carryforwards 72.4M USD +21.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 7.08M USD -40.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.68M USD +96.1%
Operating Lease, Payments 1.4M USD +75%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 26M USD +15.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%